ZD1839 (IRESSA): a selective EGFR-TK inhibitor. - Wikidata - wikimedia - TriplyDB

ZD1839 (IRESSA): a selective EGFR-TK inhibitor.

ZD1839 (IRESSA): a selective EGFR-TK inhibitor.

http://www.wikidata.org/entity/Q34734513

about

Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer FT-IR microspectrometry reveals the variation of membrane polarizability due to epigenomic effect on epithelial ovarian cancer Advances in molecular therapies in patients with brain tumors.Gefitinib therapy for advanced non-small-cell lung cancer.Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism.A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.Integrative oncoproteomics strategies for anticancer drug discovery.Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors.A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease.

P2860

Q24329242-0379740E-B80F-46A8-808E-742672EAE941 Q34486707-B991456C-E6FA-4603-BCD6-8C146306175E Q35113656-A440F454-9EF6-4786-BA54-9CC499D51673 Q35562614-78664A79-CF99-4C71-B068-1286A80290A9 Q36611021-D91D9590-800D-4719-BFB9-20FEBEB2B224 Q36906034-4BE78407-8EB9-455F-A7BB-31F9E3175617 Q37423291-55EB95FA-2AF8-421B-8D5F-2FF3BBFF6B6C Q37763937-F5AB692A-C5FF-4B6D-95C4-834366AAFBB6 Q40448827-9973CB66-7A76-423F-ADAB-C8337D4D1D90 Q53667768-BC29AFB5-56CB-4CB6-B22F-A50E133E6B85

P2860

ZD1839 (IRESSA): a selective EGFR-TK inhibitor.

http://www.wikidata.org/entity/Q34734513

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

ZD1839 (IRESSA): a selective EGFR-TK inhibitor.

@ast

ZD1839 (IRESSA): a selective EGFR-TK inhibitor.

@en

type

label

ZD1839 (IRESSA): a selective EGFR-TK inhibitor.

@ast

ZD1839 (IRESSA): a selective EGFR-TK inhibitor.

@en

prefLabel

ZD1839 (IRESSA): a selective EGFR-TK inhibitor.

@ast

ZD1839 (IRESSA): a selective EGFR-TK inhibitor.

@en

P1433

Q34734513-86E4D346-54B7-4782-8A70-A4A672317DB2

P1476

Q34734513-FC61B7E8-D16A-44BC-922A-2F31C2C511DF

P2093

Q34734513-2CA4AC72-118B-4217-9264-B19AE1770E2C

Q34734513-7BD6DEF8-8104-4358-A881-A6EB9F18CB2D

Q34734513-9379B11D-ACC4-4D19-9FF3-72B1E6F034AA

P2860

Q34734513-20ECB189-0A82-4C6B-B190-D31EEDD17021

Q34734513-41D95C9A-1C56-4186-A8B9-06467DCFDEB7

Q34734513-4FD5DA18-126B-4395-B986-38A1A2A3E78C

Q34734513-5074066F-7FA3-4AD3-B3B0-B96FF946C013

Q34734513-71EE98FB-12E5-40A1-9FBF-D518F069DB99

Q34734513-8353DAF8-0E78-45B6-9424-E3B0886A8ED2

Q34734513-946C45FA-3BC7-4C0C-9126-B36343D54ED9

Q34734513-A8155086-7760-4040-8DF0-1DE7272C4DEE

Q34734513-C81101C9-D620-4FB6-9604-E839FB94840E

Q34734513-EC9E33F1-CDBF-4428-8B28-A7D09F23BEF3

P304

Q34734513-62EEC5DF-9372-4DDD-B52B-ACC35FEA787B

P31

Q34734513-64CE367C-F9AC-4EC1-BC48-A7BA0AB8930A

P356

Q34734513-F494D172-35F6-4F29-BB9D-E70117526FE4

P433

Q34734513-887B9F8D-8CBD-41E6-A331-A43D7783AE92

P478

Q34734513-2CAFD7E8-17DC-491A-A9AC-A61E3D9CF313

P577

Q34734513-A75A59EB-B23C-495F-8D65-4D03CC609184

P698

Q34734513-95A2A0D1-99E1-4E31-A0E3-DB2E91AA2E85

P356

14737140.2.2.161

P1433

Expert Review of Anticancer Therapy

P1476

ZD1839 (IRESSA): a selective EGFR-TK inhibitor.

@en

P2093

Gordon Jayson

http://www.w3.org/2001/XMLSchema#string

Malcolm Ranson

http://www.w3.org/2001/XMLSchema#string

Was Mansoor

http://www.w3.org/2001/XMLSchema#string

P2860

Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification

Epidermal growth factor-related peptides and their receptors in human malignancies

Epidermal growth factor receptors: critical mediators of multiple receptor pathways.

Multiple positive and negative regulators of signaling by the EGF-receptor.

Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha

Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone.

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials.

Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).

Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor.

Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.

P304

161-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2.2.161

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12113238

http://www.w3.org/2001/XMLSchema#string